FDA approvaloutcome: successconf 1.00

rezlidhia — FDA approval

$RIGL · RIGEL PHARMACEUTICALS INC

Event date

December 1, 2022

1283 days ago

Sponsor runway

cash-flow +

$146.7M liquid

Evidence

“openFDA ORIG (TYPE 1) approval of REZLIDHIA — application NDA215814”

Source ↗

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)

Ticker	Drug	Date	Outcome
$INCY	zynyz	2026-05-18	success
$INCY	jakafi xr	2026-05-01	success
$AXSM	auvelity	2026-04-30	success
$INCY	zynyz	2026-03-30	success
$BIIB	spinraza	2026-03-27	success
$CORT	lifyorli	2026-03-25	success
$RYTM	imcivree	2026-03-19	success
$ASND	yuviwel	2026-02-27	success
$BMRN	palynziq	2026-02-27	success
$ETON	desmoda	2026-02-25	success

Recent insider activity· ±90 days

5 insiders · 0 buys · 4 sells

Sell

2023-02-06

RODRIGUEZ RAUL R

CEO, President

20,340 @ $1.75$36K

Sell

2023-02-02

Santos David A

EVP, Chief Commercial Officer

5,388 @ $1.66$9K

Sell

2023-02-02

Dummer Wolfgang

EVP & CMO

5,389 @ $1.66$9K

Sell

2023-02-02

Schorno Dean L

EVP & Chief Financial Officer

5,389 @ $1.66$9K

Grant

2023-01-26

RODRIGUEZ RAUL R

CEO, President

200,000 @ ——

Grant

2023-01-26

Santos David A

EVP, Chief Commercial Officer

80,000 @ ——

Grant

2023-01-26

Santos David A

EVP, Chief Commercial Officer

50,000 @ ——

Grant

2023-01-26

Santos David A

EVP, Chief Commercial Officer

160,000 @ ——

Grant

2023-01-26

Schorno Dean L

EVP & Chief Financial Officer

63,000 @ ——

Grant

2023-01-26

Schorno Dean L

EVP & Chief Financial Officer

50,000 @ ——

Grant

2023-01-26

Schorno Dean L

EVP & Chief Financial Officer

125,000 @ ——

Grant

2023-01-26

RODRIGUEZ RAUL R

CEO, President

600,000 @ ——

Grant

2023-01-26

Dummer Wolfgang

EVP & CMO

50,000 @ ——

Grant

2023-01-26

RODRIGUEZ RAUL R

CEO, President

300,000 @ ——

Grant

2022-12-28

Dummer Wolfgang

EVP & CMO

50,000 @ ——

Grant

2022-12-28

RODRIGUEZ RAUL R

CEO, President

200,000 @ ——

Grant

2022-12-28

Santos David A

EVP, Chief Commercial Officer

50,000 @ ——

Grant

2022-12-28

Schorno Dean L

EVP & Chief Financial Officer

50,000 @ ——

Grant

2022-09-14

Schorno Dean L

EVP & Chief Financial Officer

81,250 @ ——

Grant

2022-09-14

VANCE DOLLY

EVP Corp. Affairs, G.C., Sect.

81,250 @ ——

Grant

2022-09-14

RODRIGUEZ RAUL R

CEO, President

300,000 @ ——

Date	Insider	Action	Shares	Price	Value
2023-02-06	RODRIGUEZ RAUL RCEO, President	Sell	20,340	$1.75	$36K
2023-02-02	Santos David AEVP, Chief Commercial Officer	Sell	5,388	$1.66	$9K
2023-02-02	Dummer WolfgangEVP & CMO	Sell	5,389	$1.66	$9K
2023-02-02	Schorno Dean LEVP & Chief Financial Officer	Sell	5,389	$1.66	$9K
2023-01-26	RODRIGUEZ RAUL RCEO, President	Grant	200,000	—	—
2023-01-26	Santos David AEVP, Chief Commercial Officer	Grant	80,000	—	—
2023-01-26	Santos David AEVP, Chief Commercial Officer	Grant	50,000	—	—
2023-01-26	Santos David AEVP, Chief Commercial Officer	Grant	160,000	—	—
2023-01-26	Schorno Dean LEVP & Chief Financial Officer	Grant	63,000	—	—
2023-01-26	Schorno Dean LEVP & Chief Financial Officer	Grant	50,000	—	—
2023-01-26	Schorno Dean LEVP & Chief Financial Officer	Grant	125,000	—	—
2023-01-26	RODRIGUEZ RAUL RCEO, President	Grant	600,000	—	—
2023-01-26	Dummer WolfgangEVP & CMO	Grant	50,000	—	—
2023-01-26	RODRIGUEZ RAUL RCEO, President	Grant	300,000	—	—
2022-12-28	Dummer WolfgangEVP & CMO	Grant	50,000	—	—
2022-12-28	RODRIGUEZ RAUL RCEO, President	Grant	200,000	—	—
2022-12-28	Santos David AEVP, Chief Commercial Officer	Grant	50,000	—	—
2022-12-28	Schorno Dean LEVP & Chief Financial Officer	Grant	50,000	—	—
2022-09-14	Schorno Dean LEVP & Chief Financial Officer	Grant	81,250	—	—
2022-09-14	VANCE DOLLYEVP Corp. Affairs, G.C., Sect.	Grant	81,250	—	—
2022-09-14	RODRIGUEZ RAUL RCEO, President	Grant	300,000	—	—

← All catalysts for $RIGL